Inhibitory effect of nuclear factor-κb decoy oligodeoxynucleotide on liver fibrosis through regulation of the epithelial-mesenchymal transition

Human Gene Therapy

Volumn 25, Issue 8, 2014, Pages 721-729

  Kim, Kyung Hyun ^a   Lee, Woo Ram ^a   Kang, Yu Na ^b   Chang, Young Chae ^a   Park, Kwan Kyu ^a  

^a Catholic University of Daegu   (South Korea)

^b Keimyung University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIFIBROTIC AGENT; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COLLAGEN; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NUCLEAR FACTOR KAPPA B DECOY OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; DNA; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; FEASIBILITY STUDY; FIBROGENESIS; GENE THERAPY; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO GENE TRANSFER; IN VIVO STUDY; LIVER CELL; LIVER FIBROSIS; MALE; MOUSE; MURINAE; NONHUMAN; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL LINE; DRUG EFFECTS; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BINDING SITES; CELL LINE; DNA; EPITHELIAL-MESENCHYMAL TRANSITION; LIVER CIRRHOSIS; MALE; MICE, INBRED C57BL; NF-KAPPA B; PROTEIN BINDING; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84906258108     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2013.106     Document Type: Article

References (24)

1. Brenner, D.A., Waterboer, T., Choi, S.K., et al. (2000). New aspects of hepatic fibrosis. J. Hepatol. 32, 32-38.
2. Cao, C.C., Ding, X.Q., Ou, Z.L., et al. (2004). In vivo transfection of NF-jB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int. 65, 834-845.
3. Cordon-Cardo, C., and Prives, C. (1999). At the crossroads of inflammation and tumorigenesis. J. Exp. Med. 190, 1367-1370.
4. Elsharkawy, A.M., and Mann, D.A. (2007). Nuclear factor-jB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46, 590-597.
5. Friedman, S.L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275, 2247-2250.
6. Gabele, E., Brenner, D.A., and Rippe, R.A. (2003). Liver fibrosis: Signals leading to the amplification of the fibrogenic hepatic stellate cell. Front. Biosci. 8, d69-d77.
7. Iwano, M., Plieth, D., Danoff, T.M., et al. (2002). Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110, 341-350.
8. Kim, K.H., Lee, E.S., Cha, S.H., et al. (2009). Transcriptional regulation of NF-jB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy. Exp. Mol. Pathol. 86, 114-120.
9. Kim, K.H., Park, J.H., Lee, W.R., et al. (2013). The inhibitory effect of chimeric decoy oligodeoxynucleotide against NF-jB and Sp1 in renal interstitial fibrosis. J. Mol. Med. (Berl) 91, 573-586.
10. Knittel, T., Dinter, C., Kobold, D., et al. (1999). Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: Involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am. J. Pathol. 154, 153-167.
11. Lv, P., Luo, H.S., Zhou, X.P., et al. (2007). Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear factor-jB/inhibitor of nuclear factor-jB pathway. Arch. Med. Res. 38, 15-27.
12. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436-444.
13. Mehal, W.Z. (2006). Activation-induced cell death of hepatic stellate cells by the innate immune system. Gastroenterology 130, 600-603.
14. Miyake, T., Aoki, M., Nakashima, H., et al. (2006). Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFjB and ETS using chimeric decoy oligonucleotides in a rabbit model. Gene Ther. 13, 695-704.
15. Miyoshi, H.R., Rust, C., Guicciardi, M.E., and Gores, G.J. (2001). NF-jB is activated in cholestasis and functions to reduce liver injury. Am. J. Pathol. 158, 967-975.
16. Morishita, R., Higaki, J., Tomita, N., and Ogihara, T. (1998). Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ. Res. 82, 1023-1028.
17. Park, J.H., Jo, J.H., Kim, K.H., et al. (2009). Antifibrotic effect through the regulation of transcription factor using ring type- Sp1 decoy oligodeoxynucleotide in carbon tetrachlorideinduced liver fibrosis. J. Gene Med. 11, 824-833.
18. Peinado, H., Ballestar, E., Esteller, M., and Cano, A. (2004). Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol. 24, 306-319.
19. Tomita, N., Kashihara, N., and Morishita, R. (2007). Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease. Clin. Exp. Nephrol. 11, 7-17.
20. Willis, B.C., and Borok, Z. (2007). TGF-b-induced EMT: Mechanisms and implications for fibrotic lung disease. Am J. Physiol. Lung Cell. Mol. Physiol. 293, L525-L534.
21. Willis, B.C., Liebler, J.M., Luby-Phelps, K., et al. (2005). Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-b1: Potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166, 1321-1332.
22. Wu, Y., Deng, J., Rychahou, P.G., et al. (2009). Stabilization of snail by NF-jB is required for inflammation-induced cell migration and invasion. Cancer Cell 15, 416-428.
23. Zeisberg, M., and Kalluri, R. (2004). The role of epithelial- tomesenchymal transition in renal fibrosis. J. Mol. Med. (Berl) 82, 175-181.
24. Zeisberg, M., Yang, C., Martino, M., et al. (2007). Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337-23347.